ARCHIVES

Sustained-Release Leuprolide Under Study In Phase III Trial.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

Young Investigators Hold Their Own

September 28, 1979

Patient Advocates Ask HCFA To Clarify Coverage Decision.

September 8, 2000

Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions

December 13, 1985

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014